Abstract Details

Title Association between Longitudinal Increases in Serum Glucose and Metabolic Decline in Azheimer's Disease-Related Brain Regions

Topic Aging, Dementia, and Behavioral Neurology

Presentation(s) (-)

Poster/Presentation
Number 321

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Christine Burns PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Richard J. Caselli, MD, F�鶹��ýӳ�� (Mayo Clinic)	The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.
Eric M. Reiman, MD (Banner Alzheimer's Institute)	Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA.
Hideki Garren, MD, PhD (Genentech)	Dr. Garren has received personal compensation for serving as an employee of Prothena. Dr. Garren has received personal compensation for serving as an employee of Genentech. Dr. Garren has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Coya.

�鶹��ýӳ��